Advanced Solid Tumor Clinical Trials
Advanced Solid Tumor clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for advanced Solid Tumor. Corterve aggregates actively recruiting Advanced Solid Tumor studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Advanced Solid Tumor studies
- Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid TumorsNCT07086768PHASE1Lei ZhengSolid TumorSan Antonio, Texas
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsNCT06586957PHASE1NiKang Therapeutics, Inc.Solid TumorLittle Rock, Arkansas
- Anti-GD2 ADC M3554 in Advanced Solid TumorsNCT06641908PHASE1EMD Serono Research & Development Institute, Inc.Advanced Solid TumorBoston, Massachusetts
- A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)NCT05067283PHASE1Merck Sharp & Dohme LLCAdvanced Solid TumorsTampa, Florida
- FOG-001 in Locally Advanced or Metastatic Solid TumorsNCT05919264PHASE1, PHASE2Parabilis Medicines, Inc.CancerPhoenix, Arizona
- M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid TumorsNCT07166601PHASE1EMD Serono Research & Development Institute, Inc.Advanced Solid TumorNew Haven, Connecticut
- A Study of DS-1103a Combination Therapy in Participants With Advanced Solid TumorsNCT05765851PHASE1Daiichi SankyoAdvanced Solid TumorSarasota, Florida
- A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid TumorsNCT06997029PHASE1Bristol-Myers SquibbAdvanced Solid TumorBirmingham, Alabama
- A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)NCT06818643PHASE1, PHASE2Merck Sharp & Dohme LLCAdvanced Solid TumorsBirmingham, Alabama
- A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid TumorsNCT06598371PHASE1, PHASE2M.D. Anderson Cancer CenterSelect Advanced Solid TumorsHouston, Texas
- A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care TherapyNCT07161414PHASE1AstraZenecaAdvanced Solid TumorsHuntersville, North Carolina
- A Study of PHST001 in Advanced Solid TumorsNCT06840886PHASE1Pheast TherapeuticsAdvanced Solid TumorsBeverly Hills, California
Advanced Solid Tumor trials by state
Advanced Solid Tumor trials by metro
Frequently asked questions
- How do I find recruiting Advanced Solid Tumor clinical trials?
- Browse the actively recruiting Advanced Solid Tumor studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Advanced Solid Tumor clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Advanced Solid Tumor clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.